Skip to main content

Table 1 Characteristics of PCOS patients vs controls

From: Involvement of impaired CD8+ mucosal-associated invariant T cells and myeloid-derived suppressor cells in polycystic ovary syndrome

 

PCOS patients

Controls

P-value

Age, (year)

28.10±9.11

29.25±4.11

0.9897

BMI, (kg/m2)

26.26±4.29

24.93±4.15

0.1207

FSH, (IU/L)

6.46±1.70

7.08±1.90

0.0848

LH, (IU/L)

12.43±9.60

6.37±2.10

0.0002

LH/FSH

2.28±3.04

0.94±0.38

0.0073

E2, (pmol/L)

139.1±76.27

154.4±65.23

0.2907

T (nmol/L)

6.95±14.42

1.26±0.54

0.0142

PRL, (ng/ml)

22.31±49.28

16.41±8.36

0.4552

FPG, (mmol/L)

5.62±1.23

5.39±0.56

0.2716

2h PG, (mmol/L)

6.92±2.00

6.80±0.64

0.7088

FINS, (pmol/L)

16.70±14.0

12.75±6.54

0.0975

2h INS, (pmol/L)

52.40±40.50

39.55±17.92

0.0607

HOMA-IR

4.35±3.81

3.10±1.77

0.0547

  1. This table represented the clinical and biochemical characteristics of PCOS patients (n =68) and controls (n =40). All values were expressed as mean±SD. P-values were calculated by using an unpaired Student's t-test. BMI body mass index, FSH follicular stimulating hormone, LH luteinizing hormone, E2 estradiol, T testosterone, PRL prolactin, FPG fasting plasma glucose, 2h PG 2hour plasma glucose, FINS fasting insulin, 2h INS 2hour insulin, HOMA-IR homeostasis model assessment of insulin resistance